» Articles » PMID: 39444900

Rare Interstitial Lung Diseases: a Narrative Review

Overview
Journal J Thorac Dis
Specialty Pulmonary Medicine
Date 2024 Oct 24
PMID 39444900
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objective: Interstitial lung diseases (ILDs) encompass over 200 entities. Among them, fibrosing lung diseases, have recently generated special interest due to the emerging therapies for their management. However, it is important to deepen our knowledge of other less prevalent ILD, since many of them are associated with a poor prognosis. This narrative review aims to provide a practical and up-to-date description of some poorly recognized ILD. It covers rare idiopathic interstitial pneumonias and their histologic patterns, genetic disorders with interstitial lung involvement (Hermansky-Pudlak syndrome), and ILD associated with benign proliferation of pulmonary lymphoid tissue, namely follicular bronchiolitis and granulomatous-lymphocytic interstitial lung disease.

Methods: Electronic searches of PubMed and Google Scholar using specific keywords were conducted. Articles underwent screening for relevance, covering review articles, meta-analyses, systematic reviews, case series, prospective studies, society guidelines, editorials in peer-reviewed journals; scientific books on the subject. The data included was limited to English and Spanish publications.

Key Content And Findings: Despite the low prevalence of these diseases, the increased recognition of radiological patterns, pathological features, and diagnostic procedures, have permitted their better characterization. This review highlights epidemiology, clinical presentation, diagnosis, natural history, and treatment.

Conclusions: Lesser-studied ILD represent a diagnostic and therapeutic challenge and can be frequently misdiagnosed. Also, due to the lack of randomized controlled trials, there are no well-established therapeutic options. Further studies or registries are needed to improve accurate diagnosis and management.

References
1.
Verbsky J, Hintermeyer M, Simpson P, Feng M, Barbeau J, Rao N . Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency. J Allergy Clin Immunol. 2020; 147(2):704-712.e17. DOI: 10.1016/j.jaci.2020.07.021. View

2.
Itoh T, Kawasaki T, Kaiho T, Shikano K, Naito A, Abe M . Long-term nintedanib treatment for progressive pulmonary fibrosis associated with Hermansky-Pudlak syndrome type 1 followed by lung transplantation. Respir Investig. 2023; 62(1):176-178. DOI: 10.1016/j.resinv.2023.12.007. View

3.
Bates C, Ellison M, Lynch D, Cool C, Brown K, Routes J . Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol. 2004; 114(2):415-21. DOI: 10.1016/j.jaci.2004.05.057. View

4.
Lee J, Yum H, Jamous F, Santos C, Campisi A, Surani S . Diagnostic procedures and clinico-radiological findings of acute fibrinous and organizing pneumonia: a systematic review and pooled analysis. Eur Radiol. 2021; 31(10):7283-7294. DOI: 10.1007/s00330-021-07868-z. View

5.
Mark E, Ruangchira-Urai R . Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation. Ann Diagn Pathol. 2008; 12(3):171-80. DOI: 10.1016/j.anndiagpath.2007.07.002. View